Latest Breaking News On - Managing director mr joel latham - Page 1 : comparemela.com

Highlights: Incannex has engaged Catalent for the development and cGMP manufacture of Incannex’s own psilocybin drug product.The psilocybin is designed.

United statesMark bleackleyJoel lathamIncannex healthcare limited nasdaqIncannex healthcareEdison groupAustralian stock exchangeHealthcare limitedManaging director mr joel lathamChief scientific officer dr mark bleackleyGeneralised anxietyIncannex boardAmerican depository sharesSecurities litigation reform actChief executiveRelations contact